Antibe Therapeutics (ATBPF)
OTHER OTC:ATBPF
US Market
Holding ATBPF?
Track your performance easily

Antibe Therapeutics (ATBPF) Cash flow

107 Followers

Antibe Therapeutics Cash Flow

ATBPF's free cash flow for Q3 2024 was C$-3.85M. For the 2024 fiscal year, ATBPF's free cash flow was decreased by C$615.00K and operating cash flow was C$-3.85M. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 23Mar 22Mar 21Mar 20Mar 19
Operating Cash Flow
C$ -18.25MC$ -16.30MC$ -16.92MC$ -105.00KC$ -11.35MC$ -7.06M
Investing Cash Flow
C$ 18.90MC$ -11.83MC$ -20.22MC$ -264.00KC$ -461.00KC$ -257.40K
Financing Cash Flow
C$ 159.00KC$ 80.00KC$ -26.00KC$ 66.16MC$ 12.00MC$ 9.59M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
C$ 31.03MC$ 6.75MC$ 34.81MC$ 71.97MC$ 6.18MC$ 5.99M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
---C$ 69.11MC$ 8.05MC$ 5.93M
Issuance Of Debt
C$ 159.00KC$ 80.00KC$ -154.00KC$ -2.57MC$ -190.00KC$ -1.29M
Repayment Of Debt
-C$ -79.00KC$ -152.00KC$ -2.57MC$ -190.00KC$ -1.29M
Free Cash Flow
C$ -18.24MC$ -16.31MC$ -16.93MC$ -105.00KC$ -11.35MC$ -7.06M
Domestic Sales
------
Foreign Sales
------
Currency in CAD

Antibe Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis